Form 4 for AXGN Axogen, Inc.

Accepted 2026-05-08 16:07:38 ET · period of report 2026-05-07 · accession 0000805928-26-000069 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-05-08 16:07	2026-05-07	AXGN	Weiler Kathy Johnson	Dir	M - OptEx	$6.95	+16.3K	16.3K	New	+$113.6K
D	2026-05-08 16:07	2026-05-07	AXGN	Weiler Kathy Johnson	Dir	S - Sale+OE	$44.09	-16.3K	0	-100%	-$720.6K
D	2026-05-08 16:07	2026-05-07	AXGN	Weiler Kathy Johnson	Dir	M - OptEx	$0.00	-16.3K	27.3K	-37%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-05-07	M	A	16,344	$6.95	16,344	D	—	—
2	Common	Common Stock	2026-05-07	S	D	16,344	$44.09	0	D	—	—	(F1) The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.04 to $44.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
3	Derivative	Employee Stock Option (right to purchase)	2026-05-07	M	D	16,344	$0.00	27,307	D	$6.95 · — to 2033-12-20	16,344 Common Stock	(F2) Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024.